Newfeed

The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.Updated results from the ELECTRA study, evaluating elacestrant in combination with abemaciclib regardless of metastatic site, show a safety profi

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: